Ajax-Loading

Amgen Inc - Diluted Average Shares

Amgen Inc's Fiscal Year is From January To December - All Figures are in Billions.

The item "Diluted-Average-Shares" stands at 2.17 Billion for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2022.

Amgen Inc's third quarter result of 0.542 Billion for the item "Diluted Average Shares" represents an increase of 0.18 percent compared to it's second quarter result.

Also, Amgen Inc's third quarter result of 0.542 Billion for the item "Diluted Average Shares" represents no change compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Amgen Inc's third quarter result of 2.17 Billion for the item "Diluted Average Shares" represents no change compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.3242 percent compared to the value the year prior.
The 1 year change in percent is 0.3242.
The 3 year change in percent is -1.14.
The 5 year change in percent is -8.72.
The 10 year change in percent is -29.54.

The Serie's long term average value is 2.68 Billion. It's latest available value, on 09/30/2025, is 19.20 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +0.697%.
The Serie's change in percent from it's maximum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is -39.67%.

Diluted Average Shares for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Diluted Average Shares905,699,262,464.00
LogoJohnson & Johnson - Diluted Average Shares486,508,953,600.00
LogoAbbVie Inc - Diluted Average Shares399,570,305,024.00
LogoRoche Holding AG - Diluted Average Shares317,433,206,677.55
LogoAstraZeneca PLC - Diluted Average Shares280,205,508,085.11